CrossrefInfokarte
Letter: Interpreting Rule‐Out and Rule‐In Enhanced Liver Fibrosis Thresholds in Metabolic Dysfunction‐Associated Steatotic Liver Disease
Alimentary Pharmacology & Therapeutics · 2026-10-08
DOI: 10.1111/apt.71020 ↗Abstract
Kein Abstract verfügbar.
EUVIMED